Evidence map›Paper›PMID 30706176›Full record

ArticleJournal of neuro-oncology2019

Race influences survival in glioblastoma patients with KPS ≥ 80 and associates with genetic markers of retinoic acid metabolism.

Meijing Wu, Jason Miska, Ting Xiao, Peng Zhang, J Robert Kane, Irina V Balyasnikova, James P Chandler, Craig M Horbinski, Maciej S Lesniak

Abstract readComparative Study
In one paragraph

Article in Journal of neuro-oncology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 23 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Disparities in Neuro-Oncology.Current neurology and neuroscience reports · 2023
    Review
  7. RAR-Dependent and RAR-Independent RXR Signaling in Stem-like Glioma Cells.International journal of molecular sciences · 2023
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 2 countries.

Meijing WuDepartment of Neurological Surgery, Northwestern University, Chicago, IL, USA.
Jason MiskaDepartment of Neurological Surgery, Northwestern University, Chicago, IL, USA.
Ting XiaoDepartment of Neurological Surgery, Northwestern University, Chicago, IL, USA.
Peng ZhangDepartment of Neurological Surgery, Northwestern University, Chicago, IL, USA.
J Robert KaneDepartment of Neurological Surgery, Northwestern University, Chicago, IL, USA.
Irina V BalyasnikovaDepartment of Neurological Surgery, Northwestern University, Chicago, IL, USA.
James P ChandlerDepartment of Neurological Surgery, Northwestern University, Chicago, IL, USA.
Craig M HorbinskiDepartment of Neurological Surgery, Northwestern University, Chicago, IL, USA.
Maciej S LesniakDepartment of Neurological Surgery, Northwestern University, Chicago, IL, USA. maciej.lesniak@northwestern.edu.ORCID http://orcid.org/0000-0002-0096-5107
Northwestern University · US

Funding

STINGing GBM: A First-in- Man Clinical Trial in Surgical Resectable Recurrent GBMP50CA221747 · NCI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI MACIEJ S LESNIAK · 2018 to 2026
$21.4M
Therapeutic Targeting of Malignant Glioma Stem CellsR35CA197725 · NCI · UNIVERSITY OF CHICAGO · PI LESNIAK, MACIEJ S · 2015 to 2021
$6.2M
Metabolic Control of Immune Suppression in GliomasR01NS093903 · NINDS · UNIVERSITY OF CHICAGO · PI LESNIAK, MACIEJ S · 2015 to 2019
$2.3M
Intranasal Stem-Cell Based Therapy for GlioblastomaR01NS087990 · NINDS · UNIVERSITY OF CHICAGO · PI BALYASNIKOVA, IRINA V · 2014 to 2018
$2.1M
Tissue Factor as a Key Determinant of IDH1 Mutant versus IDH1 Wild-type Glioma Thrombosis and MalignancyR01NS102669 · NINDS · NORTHWESTERN UNIVERSITY AT CHICAGO · PI HORBINSKI, CRAIG MICHAEL · 2017 to 2021
$1.7M
AB FUSION PROTEINS AS SYSTEMIC BRAIN DELIVERY VEHICLESR01CA087990 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI MORRISON, SHERIE L · 2000 to 2004
$1.1M
The Significance of Isocitrate Dehydrogenase Mutations in GliomasK08CA155764 · NCI · UNIVERSITY OF KENTUCKY · PI HORBINSKI, CRAIG MICHAEL · 2011 to 2015
$857k
The Role of Glioma Metabolism in Promoting Tumor ImmunosuppressionF32NS098737 · NINDS · NORTHWESTERN UNIVERSITY AT CHICAGO · PI MISKA, JASON · 2017 to 2018
$122k
NCI NIH HHS 1F32NS098737-01A1NCI NIH HHS K08 CA155764NCI NIH HHS K08CA155764NCI NIH HHS P50 CA221747NCI NIH HHS R01 NS087990NCI NIH HHS R35 CA197725NCI NIH HHS R35CA197725NINDS NIH HHS F32 NS098737NINDS NIH HHS R01 NS087990NINDS NIH HHS R01 NS093903NINDS NIH HHS R01 NS102669Northwestern Brain Tumor Institute 10044349Northwestern Brain Tumor Institution 10044349
6 · The paper itself

Abstract

purposeTo study whether the clinical outcome and molecular biology of gliomas in African-American patients fundamentally differ from those occurring in Whites.

methodsThe clinical information and molecular profiles (including gene expression array, non-silent somatic mutation, DNA methylation and protein expression) were downloaded from The Cancer genome atlas (TCGA). Electronic medical records were abstracted from Northwestern Medicine Enterprise Data Warehouse (NMEDW) for analysis as well. Grade II-IV Glioma patients were all included.

results931 Whites and 64 African-American glioma patients from TCGA were analyzed. African-American with Karnofsky performance score (KPS) ≥ 80 have significantly lower risk of death than similar white Grade IV Glioblastoma (GBM) patients [HR (95% CI) = 0.47 (0.23, 0.98), P = 0.0444, C-index = 0.68]. Therefore, we further compared gene expression profiles between African-American GBM patients and Whites with KPS ≥ 80. Extrapolation of genes significantly associated with increased African-American patient survival revealed a set of 13 genes with a possible role in this association, including elevated expression of genes previously identified as increased in African-American breast and colon cancer patients (e.g. CRYBB2). Furthermore, gene set enrichment analysis revealed retinoic acid (RA) metabolism as a pathway significantly upregulated in African-American GBM patients who survive longer than Whites (Z-score = - 2.10, Adjusted P-value = 0.0449).

conclusionsAfrican Americans have prolonged survival with glioma which is influenced only by initial KPS score. Genes previously associated with both racial disparities in cancer and pathways associated with RA metabolism may play an important role in glioma etiology. In the future exploration of these genes and pathways may inform novel therapies for this incurable disease.

Indexed as

AdultBlack or African AmericanBrain NeoplasmsDNA MethylationFemaleGene Expression Regulation, NeoplasticGliomaHumansKarnofsky Performance StatusMaleMiddle AgedMutationNeoplasm GradingSurvival AnalysisTreatment OutcomeTretinoinTretinoinAfrican AmericansGliomaKarnofsky performance scoreRetinoic acid metabolismWhites

Identifiers

PMID30706176
PMCPMC6450757
OpenAlexW2911660854

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.